Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) for periton…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer [Phase 2]
Phase 2 trial of Antineoplaston Therapy for Stage III or Stage IV ovarian cancer was terminated. The sponsor was Burzynski Research Institut…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Mind-body Intervention to Improve Body and/or Self Image [NA]
A completed clinical trial evaluating a mind-body intervention to improve body image and self-image in women with breast cancer, ovarian can…
-
FDA approval · 2017-12-08FDA Approved: MELPHALAN HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' Melphalan hydrochloride as an original generic application.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Biobehavioral Intervention in Gynecologic Oncology Patients [Phase 2]
Phase 2 clinical trial of a biobehavioral intervention in gynecologic oncology patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating intraperitoneal natural killer cells in combination with INCB024360 for recurrent ovarian, fallopian tube, and pr…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update across multiple cancer types including ovarian, non-small cell lung, prostate, colorectal, gastric/esophageal,…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) [Phase 3]
The Phase 3 TRINOVA-2 trial of trebananib (AMG 386) in fallopian tube cancer, ovarian cancer, and primary peritoneal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy [NA]
A completed clinical trial evaluating mindfulness-based cancer recovery after chemotherapy across breast, colorectal, ovarian, and uterine c…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer [Phase 1]
A Phase 1 trial evaluating a cancer vaccine therapy in combination with sargramostim has completed in patients with stage III or IV cancer, …
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial assessing the safety and dosing of the combination of bortezomib and gemcitabine in older patients with advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer [Phase 1]
Update on a Phase 1 trial of docetaxel in patients with refractory or recurrent advanced gynecologic cancers, with the study status marked a…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial of topotecan in fallopian tube cancer, ovarian cancer, or primary peritoneal cancer; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors [Phase 1]
A Phase 1 trial evaluating amifostine to protect against side effects of peripheral stem cell transplantation in patients with solid tumors …
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: A Survivorship Care Plan for Gynaecological Cancer Patients
This completed clinical trial update reports on a survivorship care plan study for gynecologic cancer patients sponsored by Royal Marsden NH…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial of enzastaurin in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors [Phase 1]
This Phase 1 study evaluated the effects of Veliparib on heart rhythms in patients with solid tumors.
-
CLINICAL_TRIALS withdrawal · 2017-11-20Clinical Trial Update: Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating doxorubicin and carboplatin for recurrent ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer [Phase 1]
Phase 1 trial update evaluating Veliparib in combination with carboplatin and weekly paclitaxel in Japanese patients with ovarian cancer; th…
-
CLINICAL_TRIALS research · 2017-11-13Clinical Trial Update: Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer [Phase 2]
This clinical trial update describes a Phase 2 study comparing fludarabine plus pegylated liposomal doxorubicin versus pegylated liposomal d…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer [Phase 1]
An open-label Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of repeat escalating oral doses of the AKT inhibitor GSK214…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer [NA]
This study assessed intraoperative detection of cancer lesions using a PET probe during secondary cytoreductive surgery for recurrent ovaria…
-
FDA approval · 2017-11-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for doxorubicin hydrochloride from BluePoint Laboratories, adding a new approved generic version of …
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy [NA]
This clinical trial update summarizes psychosexual outcomes observed after risk-reducing salpingo-oophorectomy in individuals at risk for ov…